Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543294 · ClinicalTrials.gov registry record · NA
REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02543294: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02543294 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02543294, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.
Interventions
- BEHAVIORAL Symptom Questionnaire
- DEVICE Echocardiograms
- DEVICE Electrocardiogram
- BEHAVIORAL Telephone Follow-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-09-10 |
| Est. Completion | 2017-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02543294
The ClinicalTrials.gov registry entry for NCT02543294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Symptom Questionnaire is the first listed.
NCT02543294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02543294 about?
NCT02543294 is a clinical study titled "REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)". The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.
What is the current status of trial NCT02543294?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-09-10. Estimated completion is 2017-09-10.
What interventions are being tested in trial NCT02543294?
The interventions under investigation include: Symptom Questionnaire (BEHAVIORAL), Echocardiograms (DEVICE), Electrocardiogram (DEVICE), Telephone Follow-Up (BEHAVIORAL).
Who is sponsoring clinical trial NCT02543294?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.